2003
DOI: 10.1016/s1090-3801(02)00145-3
|View full text |Cite
|
Sign up to set email alerts
|

Prophylactic tolperisone for post‐exercise muscle soreness causes reduced isometric force—adouble‐blind randomized crossover control study

Abstract: The role of tolperisone hydrochloride, a centrally acting muscle relaxant in relieving painful muscle spasm is recently being discussed. The present study hypothesizes that the prophylactic use of tolperisone hydrochloride may effectively relieve post-exercise muscle soreness, based on the spasm theory of exercise pain. Twenty male volunteers, aged 25.2 +/- 0.82 years (mean +/- SEM) participated in 10 sessions in which they received oral treatment with placebo or the centrally acting muscle relaxant tolperison… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
12
0
2

Year Published

2006
2006
2022
2022

Publication Types

Select...
8

Relationship

1
7

Authors

Journals

citations
Cited by 22 publications
(14 citation statements)
references
References 54 publications
0
12
0
2
Order By: Relevance
“…In a double-blind randomized crossover control study Bajaj et al found that prophylactic intake of tolperisone hydrochloride (150 mg three times daily for 8 days) provides no relief to pain in course of post-exercise muscle soreness but results in reduction in isometric force [7]. …”
Section: Clinical Trials On Tolperisonementioning
confidence: 99%
“…In a double-blind randomized crossover control study Bajaj et al found that prophylactic intake of tolperisone hydrochloride (150 mg three times daily for 8 days) provides no relief to pain in course of post-exercise muscle soreness but results in reduction in isometric force [7]. …”
Section: Clinical Trials On Tolperisonementioning
confidence: 99%
“…(2-methyl-1-(4-methylphenyl)-3-(1-piperidyl) propan-1-one) is a centrally acting muscle relaxant that is used for relieving spasticity of neurological origin and muscle spasms associated with painful locomotor diseases [1][2][3]. There is little information about the pharmacokinetic behavior of tolperisone in humans, in which rapid oral absorption, very low oral bioavailability, and short elimination half-life have been observed [4,5].…”
Section: Tolperisonementioning
confidence: 99%
“…Subjects, who gave an informed written consent prior to the experiment, were randomized to ibuprofen 1,200 mg/day, 1,500 mg/day glucosamine sulphate, or placebo, respectively, taken for 22 days. On day 14 PEMS was developed in the left first dorsal interosseous [FDI] muscle by means of an exercise program carried out on an established PEMS pain model (13).…”
Section: Experimental Protocolmentioning
confidence: 99%
“…The subject's hand was positioned on the PEMS hand apparatus as described previously (13,14). On the first visit, the hand was positioned on the exerciser by fully pronating the forearm while the elbow was flexed and shoulder abducted to the right angles.…”
Section: Muscle Exercisementioning
confidence: 99%
See 1 more Smart Citation